EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SPG4 and Dementia: Expanding the Clinical Spectrum

Emanuele Panza iD, Arun Meyyazhagan iD, Eliseo Picchi iD, Gustavo Ribas iD, Ingrid Faber iD, Ryosuke Miyamoto iD, Preethi Basavaraju iD, Paolo Eusebi iD, Haripriya Kuchi Bhotla iD, Mario Stasi iD, Fabrizio Gaudiello iD, Francesco Patti iD und 8 weitere

Annals of Clinical and Translational Neurology · 2026

DOI: 10.1002/acn3.70371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2026. Verfasst von Emanuele Panza und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Dementia, Spastin. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero della Salute, Università degli Studi di Perugia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Hereditary spastic paraplegia (HSP) is a group of disorders characterized by progressive spasticity and lower limb weakness, with mutations in SPG4/ SPAST being the most common cause. Detailed studies and clinical and molecular comparisons across different populations are missing. We examined the clinical, pathological, and genetic spectrum of the SPG4/ SPAST gene in patients with HSP.

Methods

The study involved 726 HSP patients recruited from Italy, Brazil, and Japan between 2001 and 2025, with analysis conducted in collaborative centers. SPG4/ SPAST variants were identified using direct and next‐generation sequencing. The pathogenicity of novel variants was confirmed through familial segregation and in silico analysis.

Results

Clinical and epidemiological differences were observed across populations, particularly in phenotype, age at onset, and disability, expanding the SPG4 clinical spectrum. Genetic analysis identified 52 pathogenic SPG4/ SPAST mutations in 284 patients, including four novel variants. Several mutations were population‐specific, and a possible founder effect was suggested for a recurrent variant in Italy. Dementia occurred in 44 HSP‐SPG4 patients and was neuropathologically confirmed in four unrelated autopsied cases from four families comprising 28 individuals; atypical pathological features were observed in all four autopsied cases. Additionally, 18 patients with SPG4/ SPAST mutations presented with thin corpus callosum and intellectual disability.

Interpretation

In this study, we investigated pathogenic SPG4/ SPAST variants in an international cohort of HSP patients from three continents. Our findings expand the clinical spectrum of HSP‐SPG4, identifying a new type complicated by an atypical pathological form of dementia. Careful assessment of genotype–phenotype relationships offers insights into patient counseling and future research planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spastic Paraplegia, HereditaryDementiaSpastinHumansFemaleMaleMiddle AgedAdultItalyMutationBrazilAgedJapanYoung AdultPedigreePhenotypeParaplegia

Stichwörter der Autor:innen

Alzheimer's diseaseSPG4dementiahereditary spastic paraplegiathin corpus callosum

Substanzen

SpastinSPAST protein, human

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Medical Genetics Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  • Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.
  • Department of Internal Medicine, Federal University of Paraná (UFPR), Curitiba, PR, Brazil.
  • Department of Neurology, University of Brasília, Brasília, DF, Brazil.

ORCID-Profile: Emanuele Panza, Arun Meyyazhagan, Eliseo Picchi, Gustavo Ribas, Ingrid Faber, Ryosuke Miyamoto, Preethi Basavaraju, Paolo Eusebi, Haripriya Kuchi Bhotla, Mario Stasi, Fabrizio Gaudiello, Francesco Patti, Filippo Maria Santorelli, Marcondes Cavalcante França, José Luiz Pedroso, Orlando Graziani Povoas Barsottini, Hélio Afonso Ghizoni Teive, Peter Henry St George-Hyslop, Toshitaka Kawarai, Antonio Orlacchio

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Ministero della Salute
  • Università degli Studi di Perugia

Zitieren

APA

Panza, E., Meyyazhagan, A., Picchi, E., Ribas, G., Faber, I., Miyamoto, R., Basavaraju, P., Eusebi, P., Kuchi Bhotla, H., Stasi, M., Gaudiello, F., Patti, F., Santorelli, F. M., França, M. C., Pedroso, J. L., Barsottini, O. G. P., Teive, H. A. G., St George-Hyslop, P. H., Kawarai, T., & Orlacchio, A. (2026). SPG4 and Dementia: Expanding the Clinical Spectrum. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70371

Vancouver

Panza E, Meyyazhagan A, Picchi E, Ribas G, Faber I, Miyamoto R, et al. SPG4 and Dementia: Expanding the Clinical Spectrum. Annals of Clinical and Translational Neurology. 2026. doi:10.1002/acn3.70371

BibTeX
@article{Panza2026,
  author = {Panza, Emanuele and Meyyazhagan, Arun and Picchi, Eliseo and Ribas, Gustavo and Faber, Ingrid and Miyamoto, Ryosuke and Basavaraju, Preethi and Eusebi, Paolo and Kuchi Bhotla, Haripriya and Stasi, Mario and Gaudiello, Fabrizio and Patti, Francesco and Santorelli, Filippo Maria and França, Marcondes Cavalcante and Pedroso, José Luiz and Barsottini, Orlando Graziani Povoas and Teive, Hélio Afonso Ghizoni and St George-Hyslop, Peter Henry and Kawarai, Toshitaka and Orlacchio, Antonio},
  title = {SPG4 and Dementia: Expanding the Clinical Spectrum},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2026},
  doi = {10.1002/acn3.70371}
}
Kostenlos starten →